Septerna (SEPN) Non Operating Income (2023 - 2026)
Septerna (SEPN) recorded quarterly Non Operating Income of $5.0 million in Q1 2026, down 74.34% quarter-over-quarter from $19.5 million in Q4 2025, and up 17957.14% on a YoY basis from N/an in Q1 2025.
Septerna (SEPN) Non Operating Income (2023 - 2026) Analysis & Trends
Septerna's Non Operating Income history runs 4 years deep, the most recent figure standing at $5.0 million for Q1 2026.
- In Q1 2026, Non Operating Income rose 17957.14% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $30.0 million (up 251.27% YoY), while the FY2025 annual figure was $19.4 million, up 127.86% from the prior year.
- Non Operating Income was $5.0 million for Q1 2026 at Septerna, down from $19.5 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $19.5 million in Q4 2025 to a low of -$1.5 million in Q4 2023.
- Historically, Non Operating Income has averaged $3.6 million across 4 years, with a median of $1.1 million in 2023.
- Biggest YoY gain for Non Operating Income was 61866.67% in 2025; the steepest drop was 102.27% in 2025.
- A 4-year view of Non Operating Income shows it stood at -$1.5 million in 2023, then surged by 666.47% to $8.6 million in 2024, then jumped by 126.64% to $19.5 million in 2025, then slumped by 74.34% to $5.0 million in 2026.
- The last three Non Operating Income figures came in at $5.0 million (Q1 2026), $19.5 million (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | 5.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.00 Mn |
| Dec 31, 2025 | 19.49 Mn |
| Sep 30, 2025 | 5.56 Mn |
| Jun 30, 2025 | -25,000.00 |
| Mar 31, 2025 | -28,000.00 |
| Dec 31, 2024 | 8.60 Mn |
| Sep 30, 2024 | -9,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | -1.52 Mn |
| Sep 30, 2023 | 1.10 Mn |